CST3 and peripheral arterial disease: It can be viewed as an alternative predictor of complications for CVDs [37], and cystatin C could be promising as a biomarker in the diagnosis of coronary artery disease, aneurysm, adiposity, peripheral arterial disease, and coronary artery calcification [38].